ADARx Pharmaceuticals, Inc. (ADRX)
Last updated: 2026-10-21 14:44:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
ADARx Pharmaceuticals, Inc. (ADRX) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $17.91, with a market capitalization of $1.88B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.61 to $23.21. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.88B | |
$17.58 | |
$30.87 | |
$12.74 | |
$17.68 | |
44.07K | |
883.03K | |
-- | |
$23.21 | |
$16.61 | |
-- | |
-- |
ADARx Pharmaceuticals, Inc. (ADRX) Stock Price Today
ADARx Pharmaceuticals, Inc. (ADRX) is currently trading at $17.91 as of 2026-10-21 14:42:00, up 1.30% ($0.23) from the previous close of $17.68
During today's regular trading session, ADRX has traded between $12.74 and $30.87, with a trading volume of 44.07K shares. The current price is near the lower end of today's range.
ADARx Pharmaceuticals, Inc. (ADRX) 7-Day Stock Price Change
Over the past seven days, ADARx Pharmaceuticals, Inc. (ADRX) moved from $17.97 to $17.91, representing a decline of 0.33% ($0.06).
The stock traded between $16.61 and $18.82 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 389.25 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
ADRX 52-Week Price Position
Position in Range: 19.7%
ADRX is currently trading at $17.91, placing it 19.7% of the way from its 52-week low of $16.61 to its 52-week high of $23.21. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is ADARx Pharmaceuticals, Inc. (ADRX)?
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
ADARx Pharmaceuticals, Inc. Information
| Exchange | NASDAQ |
| Company Website |
How to Buy ADARx Pharmaceuticals, Inc. (ADRX) Stock on MEXC
Eligible investors can buy real shares of ADARx Pharmaceuticals, Inc. (ADRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is ADARx Pharmaceuticals, Inc. (ADRX) stock price today?
2.Is ADRX stock going up or down today?
3.What is ADRX pre-market price?
4.What is ADRX after-hours price?
5.Is ADRX stock trading now?
6.Where does ADRX sit relative to its 52-week high and low?
7.What sector is ADARx Pharmaceuticals, Inc. in?
8.What is ADARx Pharmaceuticals, Inc.'s market capitalization and where is it listed?
9.How is ADRX valued in terms of P/E ratio and EPS?
10.Does ADARx Pharmaceuticals, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ADRX Stock Calculator
Estimate the value between ADRX shares and USD.
ADRX Shares to USD
1.00 ADRX shares = 17.91 USD
Calculations are estimates based on the latest available price and are for reference only.



